Related Experiment Video
Updated: Jul 16, 2026
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Quantitative Relationship Between White Matter Hyperintensity Volume and Fazekas Score on Brain MRI
Yu-Yuan Xu1,2,3, Francesca M Chappell2,3, Maria Valdes Hernandez2,3
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University (Y.-Y.X.).
Background:
The Fazekas score is widely used to grade white matter hyperintensities (WMHs) in cerebral small vessel disease, yet the equivalent volume of each grade is unclear. We quantified the correspondence between Fazekas scores and WMH volume, normalized ratios, and derived conversion equations across populations.
Methods:
We analyzed 1220 participants from 4 mostly United Kingdom-based cohorts representing different cerebral small vessel disease severities: community-dwelling (LBC1936 [Lothian Birth Cohort 1936]), stroke (MSS2 [Mild Stroke Study 2] and MSS3 [Mild Stroke Study 3]), and a cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy-enriched cohort (INVESTIGATE [Imaging Neuro-Vascular, Endothelial and Structural Integrity in Preparation to Treat Small Vessel Diseases]). WMH burden was quantified as absolute WMH volume and as normalized ratios: WMH volume as a percentage of brain volume and WMH volume as a percentage of intracranial volume. Transition zones were defined as the overlap of WMH volume interquartile ranges between adjacent Fazekas scores. Linear, exponential (nonlinear least squares), and log-linear (ln WMH≈Fazekas score and zeros excluded) models were fitted; model fit was assessed using mean squared error, (pseudo-)R2, and Vuong tests. Periventricular-versus-deep WMH patterns within each total Fazekas score were compared using the Kruskal-Wallis test.
Results:
The pooled cohort had a mean age of 69.4±8.9 years; 700 of 1227 records (57.1%) were male. WMH burden increased monotonically with a Fazekas score in all cohorts. Adjacent-grade separation was strongest in LBC1936 (all P≤0.002) but weaker at lower grades in MSS2, MSS3, and INVESTIGATE. The widest transition zones occurred between Fazekas grades of 3 to 4 and 4 to 5, whereas a clear WMH volume gap separated grades 5 and 6. Exponential models generally fit better than linear models, with lower mean squared error and supportive Vuong tests in most cohorts. Log-linear sensitivity analyses showed similar fitted trajectories after back-transformation. WMH burden did not differ consistently by periventricular-versus-deep distribution within Fazekas grades.
Conclusions:
WMH burden followed an exponential trajectory across Fazekas scores, with population-dependent progression. The resulting conversion equations enabled bidirectional translation between visual Fazekas score and quantitative WMH volume, facilitating cross-study comparison, large-scale epidemiology, and might facilitate clinical decision-making in cerebral small vessel disease.
Insights
The Fazekas score for white matter hyperintensities (WMH) in cerebral small vessel disease correlates exponentially with WMH volume. Conversion equations derived from this study allow bidirectional translation between Fazekas scores and WMH volume for improved research and clinical use.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- The Fazekas score is a standard visual rating scale for white matter hyperintensities (WMH) in cerebral small vessel disease.
- However, the precise volumetric equivalent for each Fazekas score grade remains unclear, limiting quantitative comparisons.
- This study addresses the need for a quantitative link between the Fazekas score and WMH volume.
Purpose of the Study:
- To quantify the relationship between Fazekas scores and WMH volume across diverse patient cohorts.
- To develop conversion equations for translating between visual Fazekas scores and quantitative WMH volumes.
- To facilitate standardized cross-study comparisons and aid clinical decision-making in cerebral small vessel disease.
Main Methods:
- Analysis of 1220 participants from four UK-based cohorts (LBC1936, MSS2, MSS3, INVESTIGATE).
- WMH burden quantified by absolute volume and normalized ratios (percentage of brain/intracranial volume).
- Linear, exponential, and log-linear models fitted to assess the relationship between Fazekas scores and WMH volume.
Main Results:
- WMH burden showed a monotonic increase with Fazekas score across all cohorts.
- Exponential models provided a better fit than linear models for the WMH volume-Fazekas score relationship.
- Transition zones between adjacent Fazekas grades varied, with distinct gaps between grades 5 and 6.
Conclusions:
- WMH burden progresses along an exponential trajectory with increasing Fazekas scores, exhibiting population-specific variations.
- Developed conversion equations enable bidirectional translation between Fazekas scores and WMH volume.
- These equations support cross-study comparisons, large-scale epidemiological research, and potentially clinical decision-making in cerebral small vessel disease.
